Get started
Author

Juntao Zou

Targeted Inhibition of the E3 Ligase SCFSkp2/Cks1 Has Antitumor Activity in RB1 -Deficient Human and Mouse Small-Cell Lung Cancer
2020 · Hongling Zhao, Niloy J. Iqbal, et al. · Cancer Research · 39
Rechallenge of immune checkpoint inhibitors in advanced non‐small cell lung cancer
2024 · Gen Lin, Zhijie Wang, et al. · Thoracic Cancer · 19
PDF
Hypoxia-mediated promotion of glucose metabolism in non-small cell lung cancer correlates with activation of the EZH2/FBXL7/PFKFB4 axis
2023 · Jing Zhou, Yang Lin, et al. · Cell Death and Disease · 19
PDF
Tumor-associated macrophages affect the treatment of lung cancer
2024 · Zhuchen Yu, Juntao Zou, et al. · Heliyon · 18
The molecular subtypes of small cell lung cancer defined by key transcription factors and their clinical significance
2024 · Zhuchen Yu, Juntao Zou, et al. · Lung Cancer · 16
Feasibility and safety of EGFR-TKI neoadjuvant therapy for EGFR-mutated NSCLC: A meta-analysis
2024 · Zhuchen Yu, Fei Xu, et al. · European Journal of Clinical Pharmacology · 10
PDF
Clinical definition of secondary resistance to immunotherapy in non‐small cell lung cancer
2023 · Dingzhi Huang, Gen Lin, et al. · Thoracic Cancer · 5
PDF
N-Myc transcriptionally activates Skp2 to suppress p27 expression in small cell lung cancer
2022 · Juntao Zou, Yang Lin, et al. · Pathology - Research and Practice · 4
A real-world analysis of dyslipidemia and attributable risk in lorlatinib-treated ALK-positive lung cancer patients.
2026 · Siqing Jiang, Xingxiang Pu, et al. · Journal of Clinical Oncology
International Consensus on Severe Lung Cancer—The Second Edition
2026 · Xinqing Lin, Qian Chu, et al. · Translational Lung Cancer Research
Efficacy and safety of a low-dose nivolumab regimen (240 mg) as neoadjuvant immunochemotherapy in Chinese patients with resectable non-small cell lung cancer: a prospective single-arm, exploratory study
2026 · Zhengdong Cheng, Yating Ai, et al. · International Immunopharmacology
Efficacy and Safety of Immune Checkpoint Inhibitor Rechallenge in Advanced Lung Cancer: A Multicenter, Real-World Study
2024 · Han Hu, Ke Wang, et al. · SSRN Electronic Journal
A Mendelian randomization study confirmed a causal relationship between high basal metabolic rate levels and increased risk of lung cancer
2023 · Zhuchen Yu, Qianwen Huang, et al. · Research Square
PDF
SPIN1 accelerates tumorigenesis and confers radioresistance of non-small cell lung cancer via orchestrating the FOXO3a/FOXM1 axis
2023 · Min Zhong, Zhi Fang, et al. · Research Square
PDF
Abstract 1060: Genetic and pharmacologic inhibition of Skp2, an E3 ubiquitin ligase and RB1-target, has antitumor activity in RB1-deficient human and mouse small cell lung cancer (SCLC)
2020 · Hongling Zhao, Vineeth Sukrithan, et al. · Cancer Research
Works count: 15
Citation count: 130
H-index: 6
I10-index: 6
Year
Topic
Type